EMA WGU

Emer cooke, ema’s executive director: 2025 achievements in medicine regulation ema's executive director shares her end-of-year message and takes stock of ema's work in 2025. Only medicines evaluated by ema are available on this website.

You may not be able to obtain a complete list of available treatment options for a specific condition by searching on ema's website. The european medicines agency (ema) plays a key role in this procedure. On this page you can find several ways to contact the european medicines agency (ema) depending on your need for assistance or type of request.

While the majority of new, innovative medicines are evaluated by ema and authorised by the european commission in order to be marketed in the eu, most generic medicines and medicines available. Check ema's annual reports for insights into our regulatory procedures, activities, and achievements. The european medicines agency (ema) is responsible for the scientific evaluation of centralised marketing authorisation applications (maa).

The european medicines agency (ema) publishes detailed information on the medicines assessed by the committee for medicinal products for human use (chmp) and committee for medicinal. This complements information on medicines published on this website, which only includes medicines that the european medicines agency (ema) evaluates. Gvp apply to marketing-authorisation holders, the european medicines agency (ema) and medicines regulatory authorities in eu member states.